Two Drugs Already on the Market Show Promise Against Tuberculosis
Monday, March 26, 2012 - 14:00
in Health & Medicine
A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) -- a disease that kills 2 million people annually -- a scientist reported today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the U.S. Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics.